Rwanda vs Togo: Access to anti-retroviral drugs, female
Rwanda
97.0%
in 2024
Togo
96.0%
in 2024
Rwanda rank
12th
Togo rank
14th
Access to anti-retroviral drugs, female over time
- Rwanda
- Togo
How they compare
Rwanda currently reports 97.0% against 96.0% in Togo, a difference of 1.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Togo ahead.
Rwanda ranks 12th and Togo ranks 14th of 141 countries.
Across the 3 decades both report, Rwanda averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Rwanda | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.1% | 4.6% | 6.5% | Rwanda |
| 2010s | 63.3% | 51.6% | 11.7% | Rwanda |
| 2020s | 90.8% | 91.2% | 0.4% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Rwanda or Togo?
- Rwanda, at 97.0% against 96.0% in Togo as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Rwanda and Togo?
- 1.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Rwanda and Togo rank globally for access to anti-retroviral drugs, female?
- Rwanda ranks 12th and Togo ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.